Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Biologics
•
Pulmonology
•
Bronchiectasis
Do you use biologic agents in patients with eosinophilic bronchiectasis?
If so, what is your threshold to start?
Related Questions
Is there a role for biologics to improve lung function in patients who have severe asthma with daily symptoms and reduced lung function but do not experience frequent exacerbations?
What is your approach to the work up and evaluation of loss of asthma control while on dupilumab?
Do you utilize the bronchiectasis severity index (BSI) in your approach to managing non-CF bronchiectasis?
How do you approach initiation/continuation of biologics if there is a suspicious pulmonary nodule that requires close interval imaging (i.e every 3 or 6 months)?
What is your approach to switching from one biologic agent to another in allergic asthma/type II inflammation?
Do you use continuous or intermittent bronchodilator therapy in severe airway obstruction?
What is your approach to the use of acetazolamide in patients with OSA?
How do you manage immunosuppressive medications in patients who develop a pneumonia?
What blood pressure targets do you enforce in the first 24-48 hours in a patient who develops an intracranial hemorrhage after mechanical thrombectomy?
Do you perform PEEP titration while patients are proned?
